I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The subsequent report, first published in 2008 and seen by the Local Democracy Reporting Service, concluded: “The possibility of residual radium contamination at the Tollerton site exists, however the ...

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts ...

An announcement from Moleculin Biotech ( ($MBRX) ) is now available. On July 9, 2025, Moleculin Biotech announced that the Regulation Agency for ...

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...

Moleculin Biotech (MBRX) announced that the Regulation Agency for Medical and Pharmaceutical Activities, or RAMPA, in the country of Georgia has ...

The sNDA seeks approval for the treatment of relapsed or refractory (R/R) mutant NPM1 (mNPM1) acute myeloid leukemia/AML. The ...

Vor Biopharma pivots to telitacicept with $175M funding, eyeing multi-billion potential. Risks include dilution, regulatory ...

Cero will use Invivoscribe's multiparametric flow cytometry assay to detect minimal residual disease in patients and evaluate the therapy's efficacy.

After a leukemia diagnosis, a Rome family found support at an Atlanta Ronald McDonald House while their son underwent chemotherapy at Children’s Healthcare of Atlanta.

"I don't want her to lose anything, ever. I feel very married to what Charlotte wants," Kristin Davis tells THR about season ...